Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • GSK's Augmentin Leads...

GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report

Farhat NasimWritten by Farhat Nasim Published On 2024-11-22T17:40:39+05:30  |  Updated On 22 Nov 2024 5:40 PM IST
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time and consistently maintained its position as a market leader. Augmentin remained the top-selling drug in October, with an impressive Rs 843 crore in sales, despite slight fluctuations in unit growth, according to market research firm Pharmatrac.

Besides Augmentin, USV’s Glycomet GP also continue to lead the pack, while newer entrants like Alkem’s Pan and Abbott’s Ryzodeg have made significant strides in a rapidly changing market.

According to a recent Pharmatrac report, the rankings of the top-selling pharmaceutical brands in India have evolved, reflecting the industry's ability to adapt to the changing healthcare needs of the population. A closer analysis of both the Moving Annual Total (MAT) and Month-to-Highlight (MTH) performances for October 2024 reveals interesting trends and significant movements in the rankings of leading brands.

Top Brands by Sales Value (MAT Oct’24)

GSK’s Augmentin

GSK’s Augmentin continues to reign as the top-selling drug in India, with a sales value of Rs 843 crore for the month. Despite a slight -0.8% decline in unit growth, the brand managed to post a 1.8% increase in value for October, reinforcing its dominant position in the antibiotic market. The continued demand for Augmentin highlights its reliability and strong consumer base in the Indian healthcare system.

USV’s Glycomet GP

Glycomet GP, a leading treatment for diabetes, secures the second position with Rs 796 crore in sales. The brand saw a 4.8% increase in value year-on-year and a 3.0% rise in sales volume for October. Glycomet GP’s success reflects the growing demand for effective diabetes management solutions in India, a country that has seen an alarming rise in diabetes cases.

Abbott’s Mixtard

Abbott’s Mixtard, a popular insulin product, continues to perform strongly in the third position with Rs 747 crore in sales. The brand experienced a 3.8% growth in value and an impressive 12.5% increase in sales volume for October, reflecting the continued rise of diabetes prevalence in India and the increasing need for insulin products.

Alkem’s Pan

Alkem’s Pan has seen a remarkable rise in the rankings, moving to fourth place with Rs 726 crore in sales. The brand experienced a 10.8% value growth over the past year, and a 15.4% increase in sales volume for October. The surge in sales demonstrates Pan’s growing market share in gastrointestinal treatments, making it a key player in the therapeutic area.

Cipla’s Foracort

Foracort, Cipla’s flagship product for respiratory treatments, maintains its position in the fifth spot with Rs 724 crore in sales. The brand has seen a 6.9% increase in value over the past year, and a 7.9% rise in sales volume for October. The growing demand for respiratory medications, particularly for asthma, continues to drive Foracort’s success.

The rankings of several brands saw significant shifts in October 2024. Alkem’s Pan, driven by both value and volume growth, surged from fourth to second position. Similarly, Abbott’s Ryzodeg saw a remarkable 35.3% increase in value, along with a 24.7% rise in sales volume for the month of October. The brand’s strong performance reflects the increased demand for advanced insulin formulations in diabetes management.

FDC’s Electral also saw impressive growth, with a 29.9% increase in sales value for the year, along with a 33.0% rise in sales volume for October. The surge can be attributed to the growing demand for oral rehydration solutions, particularly in regions affected by seasonal illnesses and dehydration.

Despite the positive growth in value across several top-selling brands, volume growth remains a challenge for some. Himalaya’s Liv.52 and Aristo’s Monocef, for instance, faced declines in sales volume, with decreases of -1.0% and -13.4%, respectively. However, both brands managed to retain strong positions in the rankings due to continued value growth.

Also Read: Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA

augmetingskpharmatracindiaantibioticusvalkempanabbottryzodegciplaforacortinsulinmixtardtop selling drugoctober 2024augmetin salesglycomet gpdiabetes managementrespiratory treatmentfive top brandspharma growthpharmaceutical marketpharma latestpharma top newspharma news
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 27/May/2025

    Health Bulletin 27/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok